Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT05271292 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Chipscreen Biosciences, Ltd. |
| Last Updated on CT.gov | July 16, 2024 (Jul 16, 2024) |
As of March 2, 2026: Clinical trial NCT05271292 is currently recruiting participants. This clinical trial study for small cell lung cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by Chipscreen Biosciences, Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05271292 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05271292 was last updated Jul 16, 2024 (July 16, 2024). HelloStudys verifies this status automatically.